Specifically, we propose that miR-191 expression levels, SNP34091 genotype and the relative abundance of MDM4-S and MDM4-A contribute to the steady state levels of MDM4 protein and the activity of the p53 pathway in retinoblastoma. The gene discussed is TP53; the disease is retinoblastoma.